HLA-C and chronic myelogenous leukemia, BCR-ABL1 positive: The specific method for identifying antigen-specific TCRs from CML-specific CTLs is peptide/MHC tetramer technology; however, few specific TCRs have been identified from CML using peptide/MHC tetramer technology.